American depositary receipts of European stocks were trading 0.24% lower at 1,041.22 on the S&P/BNY Mellon Europe Select ADR Index on Thursday.
In continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and dating app owner Spark Networks (LOV), which rose 4.8% and 4.4% respectively. They were followed by furniture maker Natuzzi (NTZ) and oil and gas company TotalEnergies (TTE), which were up 1.5% and 1.4%.
The decliners in continental Europe were led by biopharmaceutical company MorphoSys (MOR) and electronics company Philips (PHG), which fell 3.1% each. They were followed by biopharmaceutical companies DBV Technologies (DBVT) and Cellectis (CLLS), which dropped 2.7 and 2.5% respectively.
In the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Verona Pharma (VRNA), which rose 1.9% and 1.8% respectively. They were followed by insurance giant Prudential (PUK) and mining company BHP Group (BHP), which were up 1.7% and 1.3%.
The decliners in the UK and Ireland were led by pharmaceutical company Avadel Pharmaceuticals (AVDL) and biopharmaceutical company Amarin Corporation (AMRN), which lost 5% and 3.4% respectively. They were followed by cruise line operator Carnival Corporation (CUK) and biopharmaceutical company NuCana (NCNA), which were down 3.2% and 3.1%.